Devin Wenig, Director at NASTECH PHARMACEUTICAL CO INC (NSTK), sold 3,000 shares at $13.75 ($41K) on 2007-05-07, disclosed to the SEC on 2007-05-09.
Scheduled sale ($41k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.51 | 100 | $1K | 3.3% |
| 2 | $13.55 | 100 | $1K | 3.3% |
| 3 | $13.56 | 400 | $5K | 13.3% |
| 4 | $13.58 | 200 | $3K | 6.6% |
| 5 | $13.59 | 300 | $4K | 10.0% |
| 6 | $13.60 | 400 |
| $5K |
| 13.3% |
| 7 | $13.61 | 200 | $3K | 6.7% |
| 8 | $13.62 | 100 | $1K | 3.3% |
| 9 | $13.63 | 100 | $1K | 3.3% |
| 10 | $13.64 | 400 | $5K | 13.3% |
| 11 | $13.66 | 100 | $1K | 3.3% |
| 12 | $13.75 | 400 | $6K | 13.4% |
| 13 | $13.95 | 100 | $1K | 3.4% |
| 14 | $13.99 | 100 | $1K | 3.4% |
| Total | $13.64 avg | 3,000 | $41K | 100% |
| Filing → |
| EBAY | SELL | 2019-07-03 | $398K | — | Filing → |
| EBAY | SELL | 2018-02-08 | $11.5M | — | Filing → |
| EBAY | SELL | 2013-10-31 | $2.4M | — | Filing → |